Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Int J Cardiol. 2014 Mar 28;174(1):90–95. doi: 10.1016/j.ijcard.2014.03.149

Table 2.

In hospital medical therapy and medication prescribed at discharge for patients with and without reinfarction.

Discharge or in hospital medication Reinfarction No reinfarction p-value

n % n %
Aspirin 165 97.6 1940 95.5 0.19
Ticlopidine or clopidogrel 117 69.2 1212 59.6 0.01
Ticlopidine 16 9.5 243 12.0 0.33
Clopidogrel 101 59.8 974 47.9 0.003
Beta blocker 149 88.2 1783 87.7 0.87
Lipid lowering drug 136 80.5 1652 81.3 0.79
ACE inhibitor or AT-1 blocker 143 84.6 1628 80.1 0.16
ACE inhibitor or ARB 138 81.7 1576 77.6 0.22
ARB 7 4.1 63 3.1 0.46
Warfarin 13 7.7 202 9.9 0.34
Glycoprotein IIb/IIIa inhibitor 3 1.8 15 0.7 0.15
Diuretics 38 22.5 333 16.4 0.04
Spironolactone 8 4.7 116 5.7 0.60
Calcium channel blocker 12 7.1 117 5.8 0.48
Long acting nitrate 30 17.8 468 23.0 0.12
Sublingual nitrate 58 34.3 594 29.2 0.16
Antiarrhythmic agent 6 3.6 78 3.8 0.85
Digoxin 5 3.0 56 2.8 0.88
Insulin 19 11.2 118 5.8 0.005
Oral antidiabetic 31 18.3 267 13.1 0.06

ACE inhibitor: Angiotensin converting enzyme inhibitor, ARB: Angiotensin receptor 1 blocker